High serum chemerin level in CKD patients is related to kidney function, but not to its adipose tissue overproduction

Renal Failure

Volumn 37, Issue 6, 2015, Pages 1033-1038

  Blaszak, Joanna ^a   Szolkiewicz, Marek ^b   Sucajtys Szulc, Elzbieta ^b   Konarzewski, Marcin ^c   Lizakowski, Slawomir ^b   Swierczynski, Julian ^b   Rutkowski, Boleslaw ^b  

^a Pomeranian Cardiology Centers   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c StWincent A Paulo Hospital   (Poland)

Author keywords

Adipokine; adipose tissue; chemerin; gene expression; renal failure

Indexed keywords

C REACTIVE PROTEIN; CHEMERIN; MESSENGER RNA; BIOLOGICAL MARKER; CHEMERIN PROTEIN, HUMAN; CHEMOKINE; SIGNAL PEPTIDE;

AGED; ARTICLE; CHEMERIN BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL EVALUATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HUMAN TISSUE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RENAL REPLACEMENT THERAPY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBCUTANEOUS FAT; ADIPOSE TISSUE; ADVERSE EFFECTS; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; KIDNEY FUNCTION TEST; METABOLISM; MIDDLE AGED; PROCEDURES; PROGNOSIS; REFERENCE VALUE; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

ADIPOSE TISSUE; AGED; AGED, 80 AND OVER; BIOMARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHEMOKINES; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; REFERENCE VALUES; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 84941568314     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2015.1040707     Document Type: Article

References (33)

1. Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol. 2010; 316: 129-139
2. Poulos SP, Hausman DB, Hausman GJ. The development and endocrine functions of adipose tissue. Mol Cell Endocrinol. 2010; 323: 20-34
3. Lehr S, Hartwig S, Sell H. Adipokines: A treasure trove for the discovery of biomarkers for metabolic disorders. Proteomics Clin Appl. 2012; 6: 91-101
4. Faber DR, de Groot PG, Visseren FL. Role of adipose tissue in hemostasis, coagulation and fibrinolysis. Obes Rev. 2009; 10: 554-563
5. Nagpal S, Patel S, Jacobe H, et al. Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin. J Invest Dermatol. 1997; 109: 91-95
6. Goralski KB, McCarthy TC, Hanniman EA, et al. Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Biol Chem. 2007; 282: 28175-28188
7. Zabel BA, Silverio AM, Butcher EC. Chemokine-like receptor 1 expression and chemerin-directed chemotaxis distinguish plasmacytoid from myeloid dendritic cells in human blood. J Immunol. 2005; 174: 244-251
8. Rourke JL, Dranse HJ, Sinal CJ. Towards an integrative approach to understanding the role of chemerin in human health and disease. Obes Rev. 2013; 14: 245-262
9. Wittamer V, Franssen JD, Vulcano M, et al. Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp Med. 2003; 198: 977-985
10. Weigert J, Obermeier F, Neumeier M, et al. Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohns disease. Inflamm Bowel Dis. 2010; 16: 630-637
11. Skrzeczynska-Moncznik J, Wawro K, Stefanska A, et al. Potential role of chemerin in recruitment of plasmacytoid dendritic cells to diseased skin. Biochem Biophys Res Commun. 2009; 380: 323-327
12. Adrych K, Stojek M, Smoczynski M, Sledzinski M, Sylwia SW, Swierczynski J. Increased serum chemerin concentration in patients with chronic pancreatitis. Dig Liver Dis. 2012; 44: 393-397
13. Kukla M, Zwirska-Korczala K, Hartleb M, et al. Serum chemerin and vaspin in non-alcoholic fatty liver disease. Scand J Gastroenterol. 2010; 45: 235-242
14. Lehrke M, Becker A, Greif M, et al. Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. Eur J Endocrinol. 2009; 161: 339-344
15. Ernst MC, Issa M, Goralski KB, Sinal CJ. Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes. Endocrinology. 2010; 151: 1998-2007
16. Chu SH, Lee MK, Ahn KY, et al. Chemerin and adiponectin contribute reciprocally to metabolic syndrome. PLoS One. 2012; 7: e34710
17. Stejskal D, Karpisek M, Hanulova Z, Svestak M. Chemerin is an independent marker of the metabolic syndrome in a Caucasian population-a pilot study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2008; 152: 217-221
18. Santoro A, Mandreoli M. Chronic renal disease and risk of cardiovascular morbidity-mortality. Kidney Blood Press Res. 2014; 39: 142-146
19. Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013; 382: 260-272
20. Pfau D, Bachmann A, Lossner U, et al. Serum levels of the adipokine chemerin in relation to renal function. Diabetes Care. 2010; 33: 171-173
21. Yamamoto T, Qureshi AR, Anderstam B, et al. Clinical importance of an elevated circulating chemerin level in incident dialysis patients. Nephrol Dial Transplant. 2010; 25: 4017-4023
22. Blaszak J, Szolkiewicz M, Sucajtys-Szulc E, Konarzewski M, Swierczynski J, Rutkowski B. High serum chemerin concentration in patients with chronic renal failure. Nefrol Dial Pol. 2013; 17: 49-52
23. Rutkowski P, Sledzinski T, Zielinska H, et al. Decrease of serum chemerin concentration in patients with end stage renal disease after successful kidney transplantation. Regul Pept. 2012; 173: 55-59
24. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987; 162: 156-159
25. Winer J, Jung CK, Shackel I, Williams PM. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem. 1999; 15: 41-49
26. Stelmanska E, Sledzinski T, Turyn J, Presler M, Korczynska J, Swierczynski J. Chemerin gene expression is regulated by food restriction and food restriction-refeeding in rat adipose tissue but not in liver. Regul Pept. 2013; 181: 22-29
27. Bozaoglu K, Bolton K, McMillan J, et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology. 2007; 148: 4687-4694
28. Svensson H, Oden B, Eden S, Lonn M. Adiponectin, chemerin, cytokines, and dipeptidil peptidase 4 are released from human adipose tissue in a depot-dependent manner: An in vitro system including human serum albumin. BMC Endocr Disord. 2014;14:7
29. Roubicek T, Bartlova M, Krajickova J, et al. Increased production of proinflammatory cytokines in adipose tissue of patients with end-stage renal disease. Nutrition. 2009; 25: 762-768
30. Chakaroun R, Raschpichler M, Kloting N, et al. Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity. Metabolism. 2012; 61: 706-714
31. John H, Hierer J, Haas O, Forssmann WG. Quantification of angiotensin-converting-enzyme-mediated degradation of humanchemerin 145-154 in plasma by matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry. Anal Biochem. 2007; 362: 117-125
32. Teta D. Adipokines as uremic toxins. J Ren Nutr. 2012;22:81-85 PubMed
33. Marchlewska A, Steinvinkel P, Lindholm B, et al. Reduced gene expression of adiponectin in fat tissue from patients with end-stage renal disease. Kidney Int. 2004; 66: 46-50